Table 2 Baseline characteristics of the patient collective: AD = antidepressants, AK = anticonvulsants, NL = neuroleptic agents, TQ = tranquilizers, MR = muscle relaxants, + = weakly effective, ++ = strongly effective, OMS = oral and maxillary surgery, TENS = ranscutaneous electric nerve stimulation, IQR = interquartile range
From: Multimodal pain therapy for persistent idiopathic facial pain - a pilot study
| Â | patients (n)] | patients (%)] |
|---|---|---|
Sex | ||
 men | 9 | 36% |
 women | 16 | 64% |
Age [Years] | ||
 56.6 (SD12.67) |  |  |
History duration [Years] | ||
 Median 9.6, (IQR 5.7,16.5 years) |  |  |
ICD Coding | ||
 G50.1 (atypical facial pain) | 10 | 40% |
 R51 (headache, facial pain) | 10 | 40% |
 G50.8 (disorders of the N. trigeminus) | 1 | 4% |
 G50.0 (trigeminal neuralgia) | 1 | 4% |
 K10.8 (mandibular disorders) | 1 | 4% |
 F45.41 (chronic pain disorder) | 1 | 4% |
 R51 + G50.0 | 1 | 4% |
Pain medication | ||
 Opioids | 8 | 36% |
 Strong | 5 | 20% |
 Weak | 3 | 12% |
 Non-opioid analgetics | 13 | 52% |
 AD | 13 | 52% |
 AK | 12 | 48% |
 NL | 1 | 4% |
 TQ | 1 | 4% |
 MR | 1 | 4% |
Concomitant disorders | ||
 internal | 14 | 56% |
 degenerative | 7 | 28% |
 neurologic | 5 | 20% |
 pain syndrome | 19 | 76% |
 psychiatric | 24 | 96% |
 psychosocial | 14 | 56% |
 physiotherapeutic | 19 | 76% |
 concomitant to PIFP | 7 | 28% |
 other | 14 | 56% |
prior operations | ||
 head, face [excl. OMS] | 10 | 40% |
 OMS | 12 | 48% |
 other | 20 | 80% |
adjunct therapies | ||
 specialist consultations | 8 | 32% |
 TENS | 6 | 24% |
 other | 14 | 56% |